Digital Health Technologies in Clinical Trials
Digital Health Technologies (DHTs) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collectio…
Tag: Design for Health Transformation
Healing vs Toxicity: how dosage can make the difference.
In a captivating interview held at Frontiers Health in Rome, Nicole Raleigh, web editor at Pharmaphorum, engages in a thought-provoking conversation w…
Assessing Parkinson’s disease severity remotely: the new frontiers of AI
A team of researchers has developed an artificial intelligence system capable of assessing the motor performance of Parkinson's patients. This discove…
The influence of AI-powered chatbots on urolithiasis treatment
Artificial Intelligence has the potential to revolutionize the healthcare industry, but how patients react to content produced by AI tools remains a q…
6 challenges healthtech can help us tackle – Pt.2
Three years after the beginning of the Covid-19 pandemic, there seems to be a shared feeling of disappointment on how little healthcare systems have c…
6 challenges healthtech can help us tackle – Pt.1
If you think about technology as simply being able to do more with less, healthcare is a great place to apply those skills” Steve Krupa, C…
Pediatric HA-VTE Prevention Challenges: Prognostic Model Insights
Hospital-acquired venous thromboembolism is a serious condition that can lead to complications and mortality in pediatric patients. Therefore, there i…
Apple Watch Series 9 and the future of Digital Health
With the introduction of the latest sensors and ongoing releases of new designs, smartwatches have led the way for advancing the field of digital heal…
Large Language Models: Revolutionizing Unstructured Data Analysis in Healthcare
In the big world of health care, the amount of unstructured data: medical records, clinical research papers, scientific publications, clinical trials,…
Debiopharm Innovation Fund Launches New Seed Funding Activity to Accelerate Digital Transformation of Cancer Care and Pharma R&D
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, today announced the launch...